Transcatheter Tumor Vascular Intervention Therapy is a minimally invasive and highly targeted approach used to treat various types of malignant tumors. This therapy includes three major procedures: Transcatheter Arterial Infusion Chemotherapy (TAI), Transcatheter Arterial Embolization (TAE), and Transcatheter Arterial Chemoembolization (TACE).

In TAI, chemotherapeutic drugs are delivered directly into the artery that supplies blood to the tumor. This allows high concentrations of the drug to act precisely where needed, enhancing effectiveness while minimizing systemic toxicity and side effects on healthy organs.

Indications

• Well-defined malignant tumors with rich blood supply
• Preoperative or postoperative chemotherapy to improve surgical outcomes and recovery
• Advanced or metastatic tumors requiring palliative or supportive therapy
• Cases where radiographic therapy is used in combination with other treatments such as targeted therapy, oral medication, or ablation

Advantages

• ✨ Minimal Trauma: This is a form of interventional therapy that does not require open surgery — only a few millimeters of skin incision, resulting in faster recovery and minimal scarring.
• ✨ Significant Therapeutic Effect: Drugs are infused directly into tumor-feeding arteries, achieving high local concentrations. Embolization further blocks blood supply, effectively “starving” the tumor and often shrinking it to enable surgical removal.
• ✨ Reduced Side Effects: Because of its localized action, the therapy minimizes systemic drug exposure, reducing toxicity and side effects compared to conventional chemotherapy.
• ✨ High Precision: Procedures are guided by advanced imaging technologies such as the DSA-MDCT composite intervention unit at Fuda Cancer Hospital, allowing dual guidance to ensure accuracy and safety.

In summary: Transcatheter Tumor Vascular Intervention Therapy represents a powerful, precise, and minimally invasive option for cancer patients. By delivering medication directly to tumors and cutting off their blood supply, it enhances efficacy, reduces systemic toxicity, and provides a viable path for treating complex or advanced cancers.